HomeStocksINDRANIB

I

Indrayani Biotech

INDRANIB Share PriceFMCG

10.43

-0.42 (-3.87%)loss
as on 13 May 2026 at 09:071D

BSE

views4
portfolio47
Overview
News
History
Fundamentals
Investment Returns
Technicals
Financials
Balance Sheet
Cash Flow
Corporate Actions
Peers
Bulb

Today Indrayani Biotech opened at 10.43 while its previous close was at 10.85. In todays trading session INDRANIB reached a high of 10.43 and low of 10.43. The average traded price for today is 10.43. The 50 DMA stands at 10.21 and 200 DMA is at 12.86. Looking at intraday trend, the stock is in Downtrend.

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

INDRANIB Stock Performance

Markets Today

High

10.43

Low

10.43

Open at

10.43

Prev Close

10.85

Volumes

10,000

Avg Price

10.43

Lower Circuit

10.31

Upper Circuit

11.39

Last Traded Details

Quantity

10,000

Time

09:07:13

Price Movement

10.4310.43
0.00%Loss
down side
up side
0.00%Profit

Historical Performance

3 M High

14.14

3 M Low

6.69

1 Yr High

19.13

1 Yr Low

6.69

3 Yr High

109.28

3 Yr Low

6.69

5 Yr High

126.81

5 Yr Low

5.21

1-Year Performance

6.6919.13
55.90%Loss
down side
up side
45.48%Profit

Get forecast for Price, ROA & ROE based on analyst ratings.

Get Forecast

INDRANIB Latest News



INDRANIB Share Price History

INDRANIB Fundamentals

Company Valuation

Market Cap (₹ Cr.)

81

PE Ratio

-11.50

PB Ratio

0.68

Dividend Yield

-

ROE

-6.11%

ROCE

3.64%

Book Value (₹)

15.96

Face Value (₹)

10.00

Analyse INDRANIB with 12+ custom fundamentals and financial ratios.

Analyse Now

Share Holding Pattern

Held ByMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters
33.28%33.28%33.26%33.26%33.26%
Domestic Institutional Investors (DII)
3.66%3.11%3.13%3.13%3.13%
Foreign Institutional Investors (FII)
0.00%0.00%0.00%0.00%0.00%
Public Investors
46.64%47.32%48.08%48.44%48.99%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government

Indrayani Biotech Return Calculator

You have invested
Investment Period

Indrayani Biotech investment value today

Current value as on today

0

Gain

-1,00,000 (58.75%)

INDRANIB Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.

INDRANIB Technicals

Moving Averages

PeriodSimpleSignal
5-SMA11.26Bearish
10-SMA11.47Bearish
20-SMA12.32Bearish
50-SMA10.21Bullish
100-SMA10.81Bullish
200-SMA12.86Bearish

Technical Indicators

IndicatorValueAction
RSI(14)44.15Neutral
ATR(14)0.78Less Volatile
STOCH(9,6)11.44Oversold
STOCH RSI(14)0.93Oversold
MACD(12,26)-0.30Bearish
ADX(14)20.43Weak Trend

Summary of Technical Indicators for INDRANIB

Margin on INDRANIB

Order TypeMargin to PayLeverageQuantityTrade ValueMargin AmountActions

*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).

INDRANIB Financials Summary

View By:
Revenue
EBITDA
Net Profit
EPS
Revenue

In Crores

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
1753303836

INDRANIB Financials

View By:

Income Statement

In Crores

Quarterly StatementDec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue1753303836
Expenses1454273432
Operating Profit3-3233
Operating Profit Margin %17%-6%7%7%8%
Other Income03121
EBITDA3-0344
Interest1-2223
Depreciation210111
Profit Before Tax0-8010
Tax %19%-3%24%14%14%
Net Profit0-9010
EPS0-1000

Balance Sheet

In Crores

Yearly Balance SheetMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Share Capital3434444646
Reserve & Surplus-15-10101824
Minority Interest00-7927
Non Current Liabilities87367166
Current Liabilities12207287103
Total Liabilities4051156234268
Fixed Assets1517586258
Capital Work in Progress1413142026
Investments00000
Other Assets112285151184
Total Assets4051156234268

Cash Flow

In Crores

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Activities0416-30-7
Investing Activities-1-1-47-1625
Financing Activities-0-33344-18
Net Cash Flow-112-3-0

Corporate Actions

DateCorporate ActionInformation
28th Apr 2026, Tuesday
RIGHTSRights
Rights Ratio 5:7
26th Feb 2026, Thursday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q3 FY 25-26 Results
info
11th Dec 2025, Thursday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q2 FY 25-26 Results
info
14th Nov 2025, Friday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q2 FY 25-26 Results
info
14th Aug 2025, Thursday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q1 FY 25-26 Results
info

The above dates are ex-dates.

Check INDRANIB latest Company Filings, Investor Presentation & Conference Call details.

Read Now

INDRANIB Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2024-2541
-37.39% Loss
1
-0.76% Loss
FY 2023-2466
-12.22% Loss
2
-71.18% Loss
FY 2022-2375
29.06% profit
5
19.67% profit

Top Mutual Funds Invested in INDRANIB

NSE Indices Today

Index NamePrice

Top Gainers Today

Stock NamePrice

Top Losers Today

Stock NamePrice

Open IPOs

What's New In The Market

FAQs on INDRANIB

Indrayani Biotech share price as of today is ₹ 10.43 as on 13 May 2026 at 09:07.
The 52W high of Indrayani Biotech is ₹ 19.13 and 52W low is ₹ 6.69 as of 13 May 2026 at 09:07.
The past returns of Indrayani Biotech share are -
  • Past 1 year: -40.37%
  • Past 3 years: -87.15%
  • Past 5 years: 58.75%
The PE and PB ratio of Indrayani Biotech stands at -11.50 and 0.68 respectively as on 13 May 2026 at 09:07.
The EPS of Indrayani Biotech is 0.01 for the quarter ended Dec 2025 and -0.35 for the financial year 2024-25.
The shareholding pattern of Indrayani Biotech is as follows:
  • DIIs - 3.13%
  • FII - 0.00%
  • Promoters - 33.26%
  • Public Investors 48.99%
  • Goverenment - 0.00%
Yes, you can buy shares of Indrayani Biotech online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Indrayani Biotech stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Indrayani Biotech share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Indrayani Biotech.
You can easily buy the shares of Indrayani Biotech even after the markets are closed using the After Market Order feature on Dhan Trading App.


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services and works closely with Raise Partners across services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com store apps sebiscores iOS: https://apps.apple.com app sebiscores.


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account. Raise Securities Private Limited (Dhan) does not engage in proprietary trading on its own account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors